Skip to content

Warren Michael Fraser, M.D.

NPI 1417146267ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Baton Rouge, LA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Baton Rouge, Louisiana, licensed in LA, with an NPI issued in October 2007. Part D covered 135 prescriptions written in 2024, 29% of them generic. Ascendis Pharma Endocrinology Inc reported $14.58 in payments in 2025, mostly food and beverage.

Overview

NPI1417146267
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedOct 17, 2007
Last updated in NPPESJan 28, 2008

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)135 · 188 30-day fills
Patients19
Total drug cost$46,316
Generic share29% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$14.58 · 1 payment from 1 company
  • 2024$61.35 · 3 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Ascendis Pharma Endocrinology Inc$14.581

What the 2025 payments were for

  • Food and Beverage$14.58 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Baton Rouge

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Louisiana →